Clinical trial NCT03638453: Pilot Feasibility of the Pediatric Cancer Resource Equity (PediCARE) Intervention
Official title: Pilot Feasibility of the Pediatric Cancer Resource Equity (PediCARE) Intervention
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Other Cancer
Keywords: Pedi Care
Lead sponsor: Dana-Farber Cancer Institute
Sponsor class: OTHER
Collaborators: name: Charles H. Hood Foundation
name: National Cancer Institute (NCI)
First posted: 2018-08-20
Enrollment: 40
Sex: ALL
Minimum age (years): 1
Maximum age (years): 17
Standard ages: CHILD
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: SUPPORTIVE_CARE

Brief summary: The goal of this new intervention is to make it easier for families to meet their basic household needs during childhood cancer treatment. The investigators want to learn how to best use PediCARE to help care for families.

Detailed description: The investigators know from previous studies that in addition to the basic worries about a child's cancer therapy, many families experience financial stress during their child's treatment. Financial stress may include difficulty paying the rent or mortgage, keeping the electricity or heat on, or putting food on the table. One of the investigators' research goals is to find ways to decrease the financial impact of treatment on each family, and make sure that financial stress does not impact a child's experience during treatment.

The investigators have developed a new supportive care intervention called PediCARE (which stands for Pediatric Cancer Resource Equity) which provides support for groceries (using an online grocery delivery service called Instacart) and transportation to and from the hospital (using rides through services such as Uber and Lyft). The investigators have evaluated the PediCARE support program in a small group of parents and used feedback from these parents to improve PediCARE. The investigators are now ready to do a feasibility study to find out whether the investigators can reliably deliver the PediCARE intervention to families.

This type of study is called a feasibility study. The goal of this research study is to learn whether the investigators can successfully give the PediCARE support program to families-in other words, whether most families are interested in participating in a randomized study about the PediCARE support program and whether they use the PediCARE support program during the study. The investigators will also begin to understand whether the PediCARE support program reduces financial stress for families during therapy. Long-term, the investigators plan to test the PediCARE support program in a larger group of randomized families to answer the question of whether PediCARE reduces financial stress for families and improves outcomes during cancer treatment

Eligibility criteria: Inclusion Criteria:

* Child newly diagnosed with cancer within 2 months;
* Planned receipt of at least 4 cycles of chemotherapy at DFCI or UAB;
* Parent/guardian screened positive for HMH\*;
* Child is \<18 years at time of enrollment
* In accordance with previous research1 families will be operationalized as having HMH for eligibility purposes if they report at least one of the below four concrete needs assessed during routine clinical care as follows:

  * Food insecurity.
  * Housing Insecurity.
  * Energy Insecurity.
  * Transportation Insecurity.

HMH screening is performed as standard of care by site-specific psychosocial providers.

Exclusion Criteria:

* Child with diagnosis of relapsed cancer;
* Child planned to receive fewer than 4 cycles of chemotherapy
* Child planned to receive observation, radiation or surgical resection only;
* Planned transfer of child to a non-DFCI or UAB facility for chemotherapy treatment;
* Foreign national family receiving cancer care as an Embassy-pay patient;
* Child is enrolled on DFCI 16-001 (due to ongoing embedded descriptive HMH study)

Primary outcomes:
measure: Percentage of Participants Recruited
timeFrame: 6-months
measure: Percentage of Attrition
timeFrame: 6-months
Secondary outcomes:
measure: Change in Household Material Hardship (HMH) in PediCARE vs Usual Care
timeFrame: 6-months
measure: Proportion of Patients With at Least One Emergency Department (ED) Visit or Intensive Care Unit (ICU) for Each Arm
timeFrame: 6 Months
Other outcomes:
Locations:
city: Boston
country: United States
facility: Dana Farber Cancer Institute
state: Massachusetts
Study officials:
affiliation: Dana-Farber Cancer Institute
name: Kira Bona, MD
role: PRINCIPAL_INVESTIGATOR
References: